Ductal adenocarcinoma of the prostate is a rare, yet aggressive, subtype of prostate cancer that diverges in clinicopathological and genomic characteristics from the more common acinar adenocarcinoma.

Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor ...

Prostate adenocarcinoma represents the most common form of prostate cancer, affecting nearly all cases diagnosed in men. This specific type develops in the gland cells that produce prostate fluid, ...

Identification of Patient-Reported Outcome Phenotypes Among Oncology Patients With Palliative Care Needs Therefore, examining patterns of treatment refusal can highlight subgroups of patients who may ...

Note benign prostatic glands for comparison on the left (a) (×200). Cribriform pattern is not recognized as HGPIN in the 5 th edition. On immunostain, HGPIN is positive for racemase and basal cell ...

Aging-US published "Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma" which reported that the authors ...

Credit: Getty Images Investigators examined 5-year prostate cancer-specific mortality rates associated with 5 histologic subtypes, 4 of them rare. Compared with the dominant subtype, acinar ...

Researchers discover a potential therapeutic avenue via neuronal endocrine receptors that could be helpful in battling an aggressive form of prostate cancer. Prostate cancer is the second most common ...

Stage 1 prostate adenocarcinoma is localized, non-aggressive, and often detected through routine screenings like PSA tests and DREs. Diagnosis involves PSA levels, Gleason scores, and possibly ...